½ÃÀ庸°í¼­
»óǰÄÚµå
1750534

¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ±â±â ½ÃÀå : ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)

Energy-based Aesthetic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 138 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ±â±â ½ÃÀåÀº 2024³â¿¡´Â 50¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, CAGR 17.9%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2034³â¿¡´Â 249¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ÀÌ ÀÇ·á±â±â´Â ºû, ÃÊÀ½ÆÄ, ·¹ÀÌÀú µî ´Ù¾çÇÑ ÇüÅÂÀÇ ¿¡³ÊÁö¸¦ ÀÌ¿ëÇÏ¿© ´Ù¾çÇÑ ¹Ì¿ë ¹®Á¦¸¦ ÇØ°áÇÕ´Ï´Ù. ÇǺΰú ¹× ¼ºÇü¿Ü°ú Ŭ¸®´Ð¿¡¼­ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ´Â ÀÌ·¯ÇÑ ±â±â´Â ÇǺÎÀÇ ¿ÜÇüÀ» °³¼±ÇÏ°í ³ëÈ­ÀÇ Â¡ÈÄ¿Í ½Î¿ì°í ´Ù¾çÇÑ Áõ»óÀ» Ä¡·áÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ºñ¸¸ À¯º´·ü »ó½ÂÀ̸ç, ¸öÀÇ À±°ûÀ» Àâ¾ÆÁÖ°í Áö¹æÀ» ÁÙÀÌ´Â Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ´ë¸¦ ¸¸µé¾î³»°í ÀÖ½À´Ï´Ù.

¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ±â±â Market-IMG1

°Ô´Ù°¡ ´Ù¿îŸÀÓÀ» °ÅÀÇ ÇÊ¿ä·Î ÇÏÁö ¾Ê´Â Ä¡·á¿¡ ´ëÇÑ ¼ÒºñÀÚ ÇൿÀÇ ½ÃÇÁÆ®´Â ºñħ½ÀÀûÀÎ ¼±ÅÃÀ» Á¡Á¡ ¸Å·ÂÀûÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. ÆíÀǼº, ¾ÈÀü¼º, ½Å¼ÓÇÑ È¸º¹À» ¿ì¼±½ÃÇÏ´Â Çö´ëÀÇ ¶óÀÌÇÁ½ºÅ¸ÀÏÀº ¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ¼Ö·ç¼ÇÀÌ Á¦°øÇÏ´Â ÀåÁ¡°ú Àß ºÎÇÕÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á°¡ ÇǺΰú³ª ¹Ì¿ëŬ¸®´Ð¿¡¼­ ³Î¸® ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÈ °Í°ú ¼Ò¼È¹Ìµð¾î ÁÖµµÀÇ ¹Ì¿ë µ¿ÇâÀÌ ¸Â¹°·Á ±× ¸Å·ÂÀº ´õ¿í °­ÇØÁö°í ÀÖ½À´Ï´Ù. ¹Ì¿ë ±â¼úÀÌ º¸´Ù Ä£¼÷Çϰí Àú·ÅÇØÁü¿¡ µû¶ó ¼ÒºñÀÚ´Â ±âÁ¸ÀÇ ¿Ü°úÀû ¼±ÅÃÁöº¸´Ù ¿¹¹æÀû Äɾ Á¶±â °³ÀÔÀ» ¼±ÅÃÇÏ°Ô µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 50¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 249¾ï ´Þ·¯
CAGR 17.9%

·¹ÀÌÀú ±â¹Ý ¹Ì¿ë ±â±â ºÎ¹®Àº 2024 ³â¿¡ 18¾ï ´Þ·¯¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¿ìÀ§¼ºÀº ÇǺΠȸÃá, ¹®½Å Á¦°Å, Áö¹æ °¨¼Ò µî ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. Á¶Á¤ °¡´ÉÇÑ ÆÄÀå, ÆÞ½º ŸÀ̹Ö, °­È­µÈ ¾ÈÀü ±â±¸ µîÀÇ ·¹ÀÌÀú ±â¼úÀÇ Çõ½ÅÀº Ä¡·áÀÇ ¸ÂÃ㼺°ú À¯È¿¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï½ÃÀå¿¡¼­´Â ¼¿ÇÁÄÉ¾î ¹× ±×·ç¹Ö¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ¼±ÁøÀûÀ̰í È¿°úÀûÀÎ ¹Ì¿ëÄ¡·á¸¦ ã´Â »ç¶÷µéÀÌ ´Ã°í ÀÖ¾î ·¹ÀÌÀú ±â¹Ý ¹Ì¿ë ±â±âÀÇ ¼ö¿äµµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

2024³â¿¡´Â ¿©¼º ºÎ¹®Àº 42¾ï ´Þ·¯¸¦ âÃâÇßÀ¸¸ç, ¾ó±¼ ȸÃá ¹× ¹Ùµð ÄÁÅõ¾î¸µ¿¡¼­ ÇǺΠź·Â°ú »ö¼Ò Ä§Âø º¸Á¤¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ½Ã¼ú¿¡ °­ÇÑ °ü½ÉÀÌ ³ªÅ¸³µ½À´Ï´Ù. ¼¿ÇÁÄÉ¾î ·çÆ¾ÀÇ Áõ°¡¿Í ÀþÀº ¿Ü¸ð¸¦ Áß½ÃÇÏ´Â »çȸÀû dzÁ¶°¡, º¸´Ù ¸¹Àº ¿©¼º¿¡°Ô Á¤±âÀûÀÎ ¹Ì¿ë Ä¡·á¸¦ ¿ä±¸Çϵµ·Ï ÀçÃËÇϰí ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ¿©¼ºÀÇ ¹Ì¿ë ¸ñÇ¥¿¡ ´ëÀÀÇÑ ¿¡³ÊÁö ±â¹Ý ±â±âÀÇ Æ÷Æ®Æú¸®¿À È®´ë¿¡ ÀÇÇØ ´õ¿í µÞ¹ÞħµÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÌ ½Ã¼úÀ» ´õ ¾ÈÀüÇϰí, ´õ Æí¾ÈÇϰí, ´õ È¿°úÀûÀ¸·Î ¸¸µé°í Àֱ⠶§¹®¿¡, ¿©¼ºÃþÀº ¾ÕÀ¸·Î ¼ö³â°£ ¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃßÁøÇÏ´Â Áö¹èÀûÀÎ ÈûÀ¸·Î Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹ÀÇ ¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ±â±â 2024³â ½ÃÀå ±Ô¸ð´Â 18¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ³ôÀº °¡Ã³ºÐ ¼Òµæ ¹× ¼ÒºñÀÚÀÇ °í±Þ ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ °­ÇÑ ±âÈ£°¡, ÀÌ·¯ÇÑ ¼ºÀåÀÇ ÁÖ¿äÇÑ ÃßÁø·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼Ò¼È ¹Ìµð¾î³ª ¹Ì¿ë ÀÎÇ÷ç¾ð¼­ÀÇ ¿µÇâ·ÂÀÌ, Àþ¾îÁö°í Àþ¾îÁø ÇǺο¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ±âÈ£¸¦ Çü¼ºÇϴµ¥ À־ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ¾î, À̰ÍÀÌ ÀÌ Áö¿ª¿¡¼­ ½ÃÀå È®´ë¸¦ ÇÑÃþ ´õ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Bausch Health Companies, Sciton, Cutera, Merz Pharma GmbH & Co, Venus Concept, Sisram Medical»ç µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº Á¦Ç° ¶óÀξ÷À» ³»½ÇÈ­ÇÏ°í ½ÃÀå¿¡¼­ÀÇ È®°íÇÑ ÁöÀ§¸¦ À¯ÁöÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå¿¡¼­ÀÇ Á¸Àç°¨À» ³ôÀ̱â À§ÇØ ¿¡³ÊÁö ±â¹ÝÀÇ ¹Ì¿ë ±â±â ¾÷°èÀÇ ±â¾÷Àº Á¦Ç° Æ÷Æ®Æú¸®¿ÀÀÇ È®´ë¿Í ±â¼ú·ÂÀÇ °­È­¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº ±â¾÷µéÀÌ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ¿© Çõ½ÅÀûÀÎ ±â´ÉÀ» ±â±â¿¡ µµÀÔÇÏ¿© Ä¡·á ¼ºÀû°ú ȯÀÚ ¸¸Á·µµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü·«Àû ÆÄÆ®³Ê½Ê, ÇÕº´, Àμö¸¦ ÅëÇØ ÆÇ¸Å¸ÁÀ» °­È­ÇÏ°í ½ÃÀå ¸®Ä¡¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. °¢»ç´Â ¶Ç, ƯÈ÷ ¹Ì¿ë Ä¡·á¿¡ÀÇ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­ÀÇ Áö¿ª È®´ë¿¡µµ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ½Ã¼ú¿¡ °üÇÑ ÀǽÄÀÇ °íÁ¶
      • ¿¡³ÊÁö ±â¹Ý ¹Ì¿ë ±â±â¿Í °ü·ÃµÈ ±â¼úÀÇ Áøº¸
      • ¼¼°è¿¡¼­ ºñ¸¸·ü »ó½Â
      • ºñħ½ÀÀû óġÀÇ Ã¤¿ë Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû À§Çè ¹× °úÁ¦
      • ¿¡³ÊÁö ±â¹ÝÀÇ ¹Ì¿ë ½Ã¼ú¿¡ µû¸¥ °íºñ¿ë
      • »óȯ ºÎÁ· ¹× ¾ö°ÝÇÑ ±ÔÁ¦ ½Ã³ª¸®¿À
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • Æ®·³ÇÁ Á¤±Ç¿¡ ÀÇÇÑ °ü¼¼¿¡ ´ëÇÑ ¿µÇâ
    • ¹«¿ª¿¡ ¹ÌÄ¡´Â ¿µÇâ
      • ¹«¿ª·®ÀÇ È¥¶õ
      • ±¹°¡º° ´ëÀÀ
    • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ
      • °ø±ÞÃøÀÇ ¿µÇâ(Á¦Á¶ ºñ¿ë)
        • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý º¯µ¿
        • °ø±Þ¸Á À籸¼º
        • »ý»ê ºñ¿ë¿¡ ¹ÌÄ¡´Â ¿µÇâ
      • ¼ö¿äÃøÀÇ ¿µÇâ(¼ÒºñÀÚÀÇ ºñ¿ë)
        • ÃÖÁ¾ ½ÃÀå¿¡ ´ëÇÑ °¡°Ý Àü´Þ
        • ½ÃÀå Á¡À¯À² µ¿Çâ
        • ¼ÒºñÀÚÀÇ ¹ÝÀÀ ÆÐÅÏ
    • ¿µÇâÀ» ¹Þ´Â ÁÖ¿ä ±â¾÷
    • Àü·«ÀûÀÎ ¾÷°è ´ëÀÀ
      • °ø±Þ¸Á À籸¼º
      • °¡°Ý ¼³Á¤ ¹× Á¦Ç° Àü·«
      • Á¤Ã¥°ü¿©
    • Àü¸Á ¹× ÇâÈÄ °ËÅä »çÇ×
  • ±â¼úÀû »óȲ
  • Àå·¡ ½ÃÀå µ¿Çâ
  • °¸ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­¹®
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç°º°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ·¹ÀÌÀú ¹Ì¿ë ±â±â
  • °íÁÖÆÄ(RF) ±â¹Ý ¹Ì¿ë ±â±â
  • ºûÀ» »ç¿ëÇÑ ¹Ì¿ë ±â±â
  • ÃÊÀ½ÆÄ ¹Ì¿ë ±â±â
  • ±âŸ Á¦Ç°

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¼ºº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ³²¼º
    • 18¼¼ ÀÌÇÏ
    • 19-34¼¼
    • 35-50¼¼
    • 51-64¼¼
    • 65¼¼ ÀÌ»ó
  • ¿©¼º
    • 18¼¼ ÀÌÇÏ
    • 19-34¼¼
    • 35-50¼¼
    • 51-64¼¼
    • 65¼¼ ÀÌ»ó

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ¹Ì¿ë¼¾ÅÍ ¹× ¸ÞµðÄà ½ºÆÄ
  • ÇǺΰú Ŭ¸®´Ð
  • Ȩ ¼³Á¤

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • Æú¶õµå
    • ½ºÀ§½º
    • ³ë¸£¿þÀÌ
    • Çɶõµå
    • ½º¿þµ§
    • µ§¸¶Å©
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ´ë¸¸
    • Àεµ³×½Ã¾Æ
    • º£Æ®³²
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • Ä¥·¹
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Apax Partners
  • Boston Scientific Corporation
  • Bausch Health Companies
  • Cutera
  • Hahn &Company
  • Merz Pharma GmbH &Co
  • Sciton
  • SharpLight Technologies
  • Sisram Medical
  • Tria Beauty
  • Venus Concept
  • Vitruvian Partners
AJY

The Global Energy-based Aesthetic Devices Market was valued at USD 5 billion in 2024 and is estimated to grow at a CAGR of 17.9% to reach USD 24.9 billion by 2034 as these medical devices utilize various forms of energy, such as light, ultrasound, and lasers, to address a wide array of cosmetic concerns. Commonly used in dermatology and plastic surgery clinics, these devices help improve skin appearance, combat signs of aging, and treat various conditions. One major factor driving market growth is the rising prevalence of obesity, creating greater demand for body contouring and fat reduction treatments.

Energy-based Aesthetic Devices Market - IMG1

Furthermore, the shift in consumer behavior toward treatments that require little to no downtime has made non-invasive options increasingly attractive. Modern lifestyles, where individuals prioritize convenience, safety, and quick recovery, align well with the benefits offered by energy-based aesthetic solutions. The widespread availability of these treatments across dermatology and aesthetic clinics, combined with social media-driven beauty trends, reinforces their appeal. As aesthetic technology becomes more accessible and affordable, consumers opt for preventive care and early interventions rather than traditional surgical options.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$5 Billion
Forecast Value$24.9 Billion
CAGR17.9%

The laser-based aesthetic device segment accounted for USD 1.8 billion in 2024. This segment's dominance is driven by a growing demand for non-invasive treatments, including skin rejuvenation, tattoo removal, and fat reduction. Innovations in laser technology, such as adjustable wavelengths, pulse timing, and enhanced safety mechanisms, are improving the customization and effectiveness of treatments. The increasing focus on self-care and grooming, especially in emerging markets, is also boosting the demand for laser-based aesthetic devices, as more individuals seek advanced, effective cosmetic treatments.

In 2024, the female segment generated USD 4.2 billion, demonstrating strong engagement across procedures-from facial rejuvenation and body contouring to skin tightening and pigmentation correction. The rise in self-care routines and the societal emphasis on youthful appearance have encouraged more women to seek regular cosmetic treatments. This trend is further supported by the expanding portfolio of energy-based devices for female aesthetic goals. As innovations continue to make procedures safer, more comfortable, and more effective, the female demographic is expected to remain the dominant force propelling growth in the energy-based aesthetic device market over the coming years.

U.S. Energy-based Aesthetic Devices Market generated USD 1.8 billion in 2024. High disposable income and a strong preference for premium aesthetic treatments among consumers are key drivers of this growth. Additionally, the influence of social media and beauty influencers has played a significant role in shaping consumer preferences toward youthful, rejuvenated skin, which further propels market expansion in the region.

Key players in the Energy-based Aesthetic Devices Market include companies like Bausch Health Companies, Sciton, Cutera, Merz Pharma GmbH & Co, Venus Concept, and Sisram Medical. These companies are committed to advancing their product offerings and maintaining strong market positions. To strengthen their market presence, companies in the energy-based aesthetic devices industry focus on expanding their product portfolios and enhancing their technological capabilities. Many are investing in research and development to introduce innovative features in their devices, improving treatment outcomes and patient satisfaction. Additionally, strategic partnerships, mergers, and acquisitions are being pursued to enhance distribution networks and extend market reach. Companies are also focusing on regional expansion, particularly in emerging markets where demand for aesthetic treatments is increasing.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing awareness regarding energy-based aesthetic procedures
      • 3.2.1.2 Technological advancements associated with energy-based aesthetic devices
      • 3.2.1.3 Rising prevalence of obesity worldwide
      • 3.2.1.4 Increasing adoption of non-invasive procedures
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with energy-based aesthetic procedures
      • 3.2.2.2 Lack of reimbursement and stringent regulatory scenario
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Trump administration tariffs
    • 3.5.1 Impact on trade
      • 3.5.1.1 Trade volume disruptions
      • 3.5.1.2 Country-wise response
    • 3.5.2 Impact on the industry
      • 3.5.2.1 Supply-side impact (Cost of Manufacturing)
        • 3.5.2.1.1 Price volatility in key materials
        • 3.5.2.1.2 Supply chain restructuring
        • 3.5.2.1.3 Production cost implications
      • 3.5.2.2 Demand-side impact (Cost to Consumers)
        • 3.5.2.2.1 Price transmission to end markets
        • 3.5.2.2.2 Market share dynamics
        • 3.5.2.2.3 Consumer response patterns
    • 3.5.3 Key companies impacted
    • 3.5.4 Strategic industry responses
      • 3.5.4.1 Supply chain reconfiguration
      • 3.5.4.2 Pricing and product strategies
      • 3.5.4.3 Policy engagement
    • 3.5.5 Outlook and future considerations
  • 3.6 Technological landscape
  • 3.7 Future market trends
  • 3.8 Gap analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Laser-based aesthetic device
  • 5.3 Radiofrequency (RF)-based aesthetic device
  • 5.4 Light-based aesthetic device
  • 5.5 Ultrasound aesthetic device
  • 5.6 Other products

Chapter 6 Market Estimates and Forecast, By Gender, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Male
    • 6.2.1 18 years and below
    • 6.2.2 19-34 years
    • 6.2.3 35-50 years
    • 6.2.4 51-64 years
    • 6.2.5 65 years and above
  • 6.3 Female
    • 6.3.1 18 years and below
    • 6.3.2 19-34 years
    • 6.3.3 35-50 years
    • 6.3.4 51-64 years
    • 6.3.5 65 years and above

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Beauty centers and medical spas
  • 7.5 Dermatology clinics
  • 7.6 Home settings

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Russia
    • 8.3.7 Poland
    • 8.3.8 Switzerland
    • 8.3.9 Norway
    • 8.3.10 Finland
    • 8.3.11 Sweden
    • 8.3.12 Denmark
    • 8.3.13 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Taiwan
    • 8.4.7 Indonesia
    • 8.4.8 Vietnam
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Colombia
    • 8.5.5 Chile
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Israel

Chapter 9 Company Profiles

  • 9.1 Apax Partners
  • 9.2 Boston Scientific Corporation
  • 9.3 Bausch Health Companies
  • 9.4 Cutera
  • 9.5 Hahn & Company
  • 9.6 Merz Pharma GmbH & Co
  • 9.7 Sciton
  • 9.8 SharpLight Technologies
  • 9.9 Sisram Medical
  • 9.10 Tria Beauty
  • 9.11 Venus Concept
  • 9.12 Vitruvian Partners
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦